We are live on ! Find out more
ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

63 hedge funds and large institutions have $96.3M invested in Oncternal Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

312% more call options, than puts

Call options by funds: $7.42M | Put options by funds: $1.8M

Holders
63
Holders Change
+63
Holders Change %
–
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
63
Increased
–
Reduced
–
Closed
–
Calls
$7.42M
Puts
$1.8M
Net Calls
+$5.62M
Net Calls Change
+$5.62M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Nomura Holdings
51
Nomura Holdings
Japan
$110K +$92.5K +12 New
BA
52
BlackRock Advisors
Delaware
$109K +$92.5K +12 New
SAM
53
Summit Asset Management
Tennessee
$95K +$77.1K +10 New
Principal Financial Group
54
Principal Financial Group
Iowa
$90K +$77.1K +10 New
U
55
UBS
Switzerland
$79K +$69.3K +9 New
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$75K +$61.6K +8 New
HCMT
57
Highland Capital Management (Tennessee)
Tennessee
$70K +$61.6K +8 New
OC
58
Oppenheimer & Co
New York
$66K +$53.9K +7 New
DAM
59
Delta Asset Management
Tennessee
$46K +$38.5K +5 New
TCM
60
TD Capital Management
Tennessee
$14K +$15.4K +2 New
Ameriprise
61
Ameriprise
Minnesota
$12K +$7.71K +1 New
California Public Employees Retirement System
62
California Public Employees Retirement System
California
$9K +$7.71K +1 New
BlackRock
63
BlackRock
New York
$5K +$7.71K +1 New
Citigroup
64
Citigroup
New York
$2K – – –
MFS
65
MSI Financial Services
Massachusetts
$1K – – –
RFC
66
Russell Frank Company
Washington
$1K – – –
1 2
3

ONCT Hedge Fund Activity: Q2 2013 in Review

63 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q2 2013, worth a combined $96.3M.

Buyers outnumbered sellers: 63 funds opened new ONCT positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.

  • 63 institutional investors held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $96.3M of Oncternal Therapeutics, Inc. Common Stock stock for Q2 2013.
  • 63 funds opened new Oncternal Therapeutics, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +63 holders.

Based on aggregated 13F filings for Q2 2013.